Organization · Venture Debt
Kreos Capital
Kreos Capital is a provider of growth and venture debt financing, focusing on equity-backed, high-growth companies in the technology and healthcare sectors across Europe and Israel.
Overview
What Kreos Capital does
What Kreos Capital is
Kreos Capital is a provider of growth and venture debt financing, focusing on equity-backed, high-growth companies in the technology and healthcare sectors across Europe and Israel.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Debt
- Founded
- Founded in 1998
- Approximate age
- About 28 years
- Structured capabilities
- Funder
- Last reviewed
- April 8, 2026
What Venture debt means
Venture debt is a loan or credit facility designed for high-growth startups, typically companies that have already raised institutional venture capital and may not qualify for traditional bank debt because they lack profitability, long operating history, predictable cash flow, or hard collateral.
Open the glossary entryOfficial channels
Find Kreos Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Kreos Capital as a funder
Investment thesis
Kreos Capital provides growth and venture debt financing to high-growth companies, focusing on innovative and flexible debt solutions.
Focus narrative
Kreos Capital specializes in providing innovative and flexible debt solutions to equity-backed, high-growth companies in Europe and Israel. The firm focuses on various sectors, including technology (fintech, enterprise software, cybersecurity, semiconductors, digital marketing, AI) and healthcare (drug development, medical products, healthcare technology). Kreos Capital supports companies at all stages of growth, from entry-level to late-stage and pre-IPO funding.
Focus and fit
- Stages
- Friends and Family · Angel · Accelerator · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity · Pre-IPO
- Sectors
- Fintech · Cybersecurity · AI · Healthcare · Biotech · Medical Devices
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 570
Portfolio context
Kreos Capital has financed over 750 transactions, representing a diverse portfolio of high-growth companies. Notable portfolio companies include: Vivino: A wine app that allows users to scan and rate wines. Taxfix: A tax filing app that simplifies the tax return process. Docplanner: A healthcare appointment booking platform. Calliditas: A biopharmaceutical company focused on developing treatments for kidney diseases. Abivax: A clinical-stage biotechnology company focused on developing treatments for inflammatory diseases.
Common questions
What to know about Kreos Capital
Upseed classifies Kreos Capital under the Venture Debt organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 8, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.